Edu Butyrose
  • Responsabile scientifico
  • Articoli
    • BARRIERA EPITELIALE INTESTINALE
    • BUTIRRATO
    • COVID-19
    • GVHD – Graft-versus-Host Disease / Malattia del trapianto contro l’ospite
    • IBS
    • IBD
    • IDROSADENITE SUPPURATIVA
    • LINEE GUIDA
    • MALATTIE METABOLICHE
    • MALATTIA DIVERTICOLARE
    • RADIOTERAPIA
    • RIGENERAZIONE CUTANEA
  • Interviste
  • Eventi
  • Studi in corso
  • Riviste
  • Documenti utili
  • LSC
  • SILA
  • Logout
Seleziona una pagina
Microbiome Modulation in Pediatric Leukemia: Impact on Graft-Versus-Host Disease and Treatment Outcomes: A Narrative Review

Microbiome Modulation in Pediatric Leukemia: Impact on Graft-Versus-Host Disease and Treatment Outcomes: A Narrative Review

da admin | Ago 6, 2026 | GVHD - Graft-versus-Host Disease / Malattia del trapianto contro l'ospite

Non hai il permesso di visualizzare questo contenuto.
Microbiome Modulation in Pediatric Leukemia: Impact on Graft-Versus-Host Disease and Treatment Outcomes: A Narrative Review

Fecal microbiota transplantation for refractory chronic graft‑versus‑host disease after allogeneic hematopoietic cell transplantation: a pilot open‑label, Non‑placebo‑controlled study

da admin | Ago 6, 2026 | GVHD - Graft-versus-Host Disease / Malattia del trapianto contro l'ospite

Non hai il permesso di visualizzare questo contenuto.
Microbiome Modulation in Pediatric Leukemia: Impact on Graft-Versus-Host Disease and Treatment Outcomes: A Narrative Review

Oral Sodium Butyrate Supplementation, Gut Microbiome Modulation, and Reduced Acute GraftVersus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

da admin | Ago 6, 2026 | GVHD - Graft-versus-Host Disease / Malattia del trapianto contro l'ospite

Non hai il permesso di visualizzare questo contenuto.
Microbiome Modulation in Pediatric Leukemia: Impact on Graft-Versus-Host Disease and Treatment Outcomes: A Narrative Review

Impact of oral butyrate on clinical and biochemical parameters in IBD: A randomized placebo-controlled study targeting gut microbiota

da admin | Dic 23, 2025 | LETTERATURA BUTYROSE

Impact of oral butyrate on clinical and biochemical parameters in IBD: A randomized placebo-controlled study targeting gut microbiota Sonia Facchin, Matteo Calgaro, Mattia Pandolfo, Andrea Buda, Brigida Barberio, Fabiana Zingone, Nicola Vitulo, Edoardo Vincenzo...
Microbiome Modulation in Pediatric Leukemia: Impact on Graft-Versus-Host Disease and Treatment Outcomes: A Narrative Review

LESIONE DA DECUBITO IN REGIONE SACRALE + FERITA CHIRURGICA CON CUTE ABRASA E ESCORIATA DOPO LA RIMOZIONE DEI PUNTI DI SUTURA

da admin | Dic 23, 2025 | CASI CLINICI

LESIONE DA DECUBITO IN REGIONE SACRALE + FERITA CHIRURGICA CON CUTE ABRASA E ESCORIATA DOPO LA RIMOZIONE DEI PUNTI DI SUTURA Giulia Bisello – Infermiera Professionale Medicina di gruppo integrata Mogliano Veneto (TV) Visualizza...
« Post precedenti
Post successivi »

Articoli recenti

  • Global guidelines on diverticular disease of the colon: the Fiesole Consensus report
  • Gut microbiota in symptomatic uncomplicated diverticular disease stratifies by severity of abdominal pain
  • Micro-encapsulated and colonic-release sodium butyrate modulates gut microbiota and improves abdominal pain in patients with symptomatic uncomplicated diverticular disease
  • Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis—a prospective randomized study
  • Rifaximin in diverticulosis and diverticular disease: a national survey among Italian gastroenterologists and general practitioners

Commenti recenti

    ideA-Z Project in progress S.r.l. | P.IVA: IT03373190960
    Corso Giacomo Matteotti, 48 – 20081 – Abbiategrasso (MI) | info@idea-z.it